ARDX Forecast. What You Should Know.
ARDX Historical Ratings and Targets
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.